AnalystsYun ZhongYun Zhong's Stock Forecasts
AnalystsYun Zhong
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#5062 out of 5081 analysts
Average Return
-17.48%
Win Rate
38%16 out of 42
Risk vs Reward
Poor
Good
Yun Zhong's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Camp4 Therapeutics CorpCAMP | +93.97% | $1.99 | $3.86 | 2025-05-26 - 2025-10-29 | Buy |
Tectonic Therapeutic IncTECX | +77.07% | $9.42 | $16.68 | 2022-12-07 - 2023-12-07 | Strong Buy |
Rezolute IncRZLT | +75.18% | $5.44 | $9.53 | 2024-11-04 - 2025-10-29 | Buy |
Protagonist Therapeutics IncPTGX | +67.08% | $45.90 | $76.69 | 2024-11-04 - 2025-10-29 | Buy |
Protagonist Therapeutics IncPTGX | +56.89% | $48.88 | $76.69 | 2025-03-27 - 2025-10-29 | Buy |
Yun Zhong Analyst Color
Get additional color on Yun Zhong's coverage of popular stocks
Yun Zhong's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Opus Genetics IncIRD | 1 | Buy | $8.00 | +304.04% | Initiates Coverage On | a day ago |
Protagonist Therapeutics IncPTGX | 3 | Buy | $86.00 | +12.14% | Maintains | 2 days ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $18.00 | +87.30% | Maintains | a month ago |
Passage Bio IncPASG | 3 | Buy | $40.00 | +438.36% | Maintains | 3 months ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $28.00 | +236.13% | Initiates Coverage On | 3 months ago |
Ascendis Pharma AASND | 2 | Buy | $220.00 | +6.95% | Maintains | 3 months ago |
Voyager Therapeutics IncVYGR | 1 | Buy | $8.00 | +73.54% | Maintains | 3 months ago |
Wave Life Sciences LtdWVE | 1 | Buy | $18.00 | +117.92% | Reiterates | 4 months ago |
Keros Therapeutics IncKROS | 2 | Hold | $15.00 | -0.27% | Reiterates | 5 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Buy | $8.00 | +107.25% | Initiates Coverage On | 5 months ago |
Rocket Pharmaceuticals IncRCKT | 2 | Buy | $32.00 | +746.56% | Reiterates | 5 months ago |
Rezolute IncRZLT | 1 | Buy | $12.00 | +25.92% | Initiates Coverage On | a year ago |
Anavex Life Sciences CorpAVXL | 2 | Strong Buy | $28.00 | N/A | Maintains | 3 years ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Sarepta Therapeutics IncSRPT | 4 | Strong Buy | $160.00 | N/A | Maintains | 3 years ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Tectonic Therapeutic IncTECX | 2 | Strong Buy | $48.00 | N/A | Upgrades | 3 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Renovacor IncRCOR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Strong Buy | $75.00 | N/A | Maintains | 3 years ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 4 years ago |
Bluebird Bio IncBLUE | 2 | Hold | $700.00 | N/A | Downgrades | 4 years ago |
Uniqure NvQURE | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 4 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Sio Gene Therapies IncSIOX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 4 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 4 years ago |
Mereo Biopharma Group PLCMREO | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Nightstar Therapeutics PLCNITE1 | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.